These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 19563348)
1. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study. Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348 [TBL] [Abstract][Full Text] [Related]
2. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308 [TBL] [Abstract][Full Text] [Related]
3. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131 [TBL] [Abstract][Full Text] [Related]
5. Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial. Korian Topiramate Study Group Seizure; 2002 Jun; 11(4):255-60. PubMed ID: 12027573 [TBL] [Abstract][Full Text] [Related]
6. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group. Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342 [TBL] [Abstract][Full Text] [Related]
7. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development. Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135 [TBL] [Abstract][Full Text] [Related]
8. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Brodie MJ; Kelly K; Stephen LJ Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766 [TBL] [Abstract][Full Text] [Related]
9. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy. Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B; Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865 [TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J; Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
12. Topiramate in refractory epilepsy: a prospective observational study. Stephen LJ; Sills GJ; Brodie MJ Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624 [TBL] [Abstract][Full Text] [Related]
13. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453 [TBL] [Abstract][Full Text] [Related]
14. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy. Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B; Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA; Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378 [TBL] [Abstract][Full Text] [Related]
17. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
18. Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials. Uthman BM; Bazil CW; Beydoun A; Schulze-Bonhage A; Benabou R; Whalen E; Emir B; Griesing T; Leon T Epilepsia; 2010 Jun; 51(6):968-78. PubMed ID: 20345940 [TBL] [Abstract][Full Text] [Related]
19. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals. Giannakodimos ST; Georgiadis G; Tsounis ST; Triantafillou N; Kimiskidis V; Giatas K; Karlovasitou A; Mitsikostas DD; Thodi E; Polychronopoulos P; Ramopoulos N; Michailidis K; Michalis N; Garganis K; Gatzonis ST; Balogiannis ST; Kazis AR; Milonas J; Van Oene JC Seizure; 2005 Sep; 14(6):396-402. PubMed ID: 16019237 [TBL] [Abstract][Full Text] [Related]
20. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group. Abou-Khalil B Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]